SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001005286-23-000032
Filing Date
2023-02-01
Accepted
2023-01-31 17:47:32
Documents
12
Period of Report
2023-01-31
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 8-K lndc-20230131.htm   iXBRL 8-K 41367
  Complete submission text file 0001005286-23-000032.txt   179402

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lndc-20230131.xsd EX-101.SCH 1981
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lndc-20230131_lab.xml EX-101.LAB 24137
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lndc-20230131_pre.xml EX-101.PRE 12589
6 EXTRACTED XBRL INSTANCE DOCUMENT lndc-20230131_htm.xml XML 11054
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

IRS No.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0528
Type: 8-K | Act: 34 | File No.: 000-27446 | Film No.: 23573786
SIC: 2834 Pharmaceutical Preparations